shutterstock_648346156
News
European Commission approves CSL’s ANDEMBRY for the prevention of recurrent attacks of hereditary angioedema
The European Commission (EC) has approved CSL's ANDEMBRY (garadacimab), the first and only once-monthly treatment targeting factor XIIa to prevent attacks of hereditary angioedema (HAE)...
GSK’s 5-in-1 meningococcal vaccine approved by US FDA
The US Food and Drug Administration (FDA) has approved GSK's Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10...
Infex and Justus-Liebig-University Giessen awarded £1m grant to develop antimicrobial drug targeting multi-drug-resistant bacteria
Infex Therapeutics, an anti-infectives specialist, in collaboration with Justus-Liebig-University Giessen (JLU), Germany, has been awarded a £1 million grant from PACE (Pathways to Antimicrobial...
